What are GLP-1 research peptides?
GLP-1 research peptides are synthetic peptides used in laboratory research to study the glucagon-like peptide-1 receptor pathway and related metabolic signaling. In research models, these compounds are investigated for how they interact with incretin receptors that influence insulin secretion, glucagon, and gastric signaling. Examples studied in this category include semaglutide, tirzepatide, and retatrutide. These materials are supplied for research use only and are not for human or animal consumption. They are tools for in-vitro and laboratory investigation, not drug products.
How does semaglutide work in research models?
In research models, semaglutide acts as a GLP-1 receptor agonist, meaning it binds and activates the glucagon-like peptide-1 receptor. Studies in laboratory systems examine how this activation influences glucose-dependent insulin signaling, glucagon suppression, and slowed gastric signaling pathways. Researchers also study its extended half-life, which is attributed to structural modifications that resist enzymatic degradation and promote albumin binding. This description reflects mechanisms observed in research contexts. The research-grade material is for laboratory use only, is not the prescription drug product, and is not for human or animal use.
What is the difference between semaglutide and tirzepatide?
The primary difference studied in research models is receptor targeting. Semaglutide is a single-agonist peptide acting on the GLP-1 receptor alone. Tirzepatide is a dual-agonist peptide investigated for activity at both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. Research compares how single versus dual incretin receptor engagement affects metabolic signaling in laboratory systems. Both are supplied as research-use-only materials, not for human or animal consumption. Any approved or investigational pharmaceutical forms are separate from this research-grade material.
What is retatrutide?
Retatrutide is a peptide studied in research models as a triple receptor agonist, investigated for simultaneous activity at the GLP-1, GIP, and glucagon receptors. Laboratory research examines how engaging all three incretin and glucagon pathways influences metabolic signaling compared with single- or dual-agonist peptides. Retatrutide is currently an investigational compound in pharmaceutical development. The research-grade material offered here is for laboratory and in-vitro research use only, is not for human or animal consumption, and is a research tool, not a drug product.
What is the incretin effect?
The incretin effect describes the observation, studied in research models, that orally delivered glucose produces a greater insulin response than an equivalent amount delivered intravenously. This difference is attributed to gut-derived hormones called incretins, primarily GLP-1 and GIP, which are released in response to nutrient signaling and amplify glucose-dependent insulin secretion. Researchers study incretin peptides to understand this signaling pathway in laboratory and cell-based systems. Peptides referenced in this context are research-use-only materials, not for human or animal consumption, and not intended for any therapeutic application.
What is GIP and how does it relate to GLP-1?
GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone studied alongside GLP-1 for its role in glucose-dependent insulin signaling. In research models, both GIP and GLP-1 are released in response to nutrient intake and act on distinct receptors that influence insulin secretion. Dual-agonist peptides such as tirzepatide are investigated for engaging both pathways at once, while triple agonists add glucagon receptor activity. Researchers study these combinations to compare metabolic signaling. The peptides discussed are research-use-only materials, not for human or animal consumption.
How is AOD 9604 different from GLP-1 peptides?
AOD 9604 differs mechanistically from GLP-1 peptides. It is a fragment derived from the C-terminal region of human growth hormone, studied in research models for its effects on lipid metabolism signaling rather than the incretin receptor pathway. Unlike semaglutide or tirzepatide, AOD 9604 does not act as a GLP-1 or GIP receptor agonist. Researchers investigate it within growth-hormone-related fat metabolism studies. AOD 9604 is supplied for research use only, is not for human or animal consumption, and is a distinct laboratory research tool, not an incretin peptide.
What is tesamorelin studied for?
Tesamorelin is a growth-hormone-releasing hormone (GHRH) analog studied in research models for its interaction with GHRH receptors and downstream effects on growth hormone signaling. Laboratory research examines its stabilized structure, which is designed to resist enzymatic breakdown, and its role in studies of lipid and metabolic pathways. It is mechanistically distinct from GLP-1 incretin peptides. Tesamorelin is offered as a research-use-only material, is not for human or animal consumption. Any approved pharmaceutical form is separate from this research-grade material.
Why do these peptides have such different half-lives?
Half-life differences studied in research models are attributed to structural modifications that affect enzymatic stability and protein binding. Semaglutide, for example, includes modifications promoting albumin binding and resistance to degradation, which extend its measured half-life in laboratory systems. Shorter peptides or unmodified fragments such as AOD 9604 are typically cleared faster. Researchers study these structural and pharmacokinetic differences to understand stability and signaling duration in vitro. All half-life observations reference research contexts. These materials are research-use-only, not for human or animal consumption.
Are research-grade semaglutide and the prescription drug the same thing?
No. Research-grade semaglutide and the prescription pharmaceutical product are not the same thing. Semaglutide, tirzepatide, and retatrutide have approved or investigational pharmaceutical forms produced under regulated drug manufacturing for separate purposes. The research-grade material offered here is supplied for laboratory and in-vitro research use only. It is not a drug product, is not formulated or labeled for therapeutic use, and is not for human or animal consumption. Researchers should treat it strictly as a laboratory reagent and never as a substitute for any pharmaceutical product.
What sizes are these supplied in?
Metabolic research peptides are typically supplied as lyophilized (freeze-dried) powder in sealed vials measured in milligrams, with common research quantities ranging across single-vial and multi-vial configurations depending on the compound. Exact available sizes for semaglutide, tirzepatide, retatrutide, AOD 9604, and tesamorelin are listed on each product page. All vials are intended for laboratory research use only and are not for human or animal consumption. Researchers should consult the specific product listing for current milligram amounts, purity documentation, and packaging details before placing a research order.
How are GLP-1 peptides reconstituted and stored for research?
In research settings, lyophilized GLP-1 peptides are generally reconstituted with a suitable sterile solvent such as bacteriostatic or sterile water, added gently against the vial wall to avoid disrupting the peptide. Lyophilized powder is typically stored frozen and protected from light, while reconstituted solutions are usually refrigerated and used within a limited window. Specific handling depends on the compound and the research protocol. These procedures apply to laboratory research use only. The materials are not for human or animal consumption, and reconstitution does not make them suitable for any therapeutic application.
Why is purity important for incretin peptide research?
Purity is important because impurities, residual solvents, or truncated peptide fragments can confound experimental results in incretin research. Higher purity, often verified by HPLC and mass spectrometry, helps researchers attribute observed effects to the target peptide rather than contaminants. Consistent purity also supports reproducibility across laboratory studies of GLP-1 and GIP receptor signaling. For this reason, research peptides are commonly accompanied by purity documentation. These materials remain research-use-only, are not for human or animal consumption, and are not FDA approved as research reagents regardless of their measured purity.
Which GLP-1 peptide is studied most?
Semaglutide is among the most widely referenced GLP-1 peptides in published research models, owing to extensive study of single GLP-1 receptor agonism and its extended half-life. Tirzepatide has also become heavily studied as a dual GLP-1 and GIP agonist, and retatrutide draws growing research interest as a triple agonist. Research focus shifts as new mechanistic studies appear. These comparisons reflect research literature, not product recommendations. All such peptides are supplied for laboratory research use only and are not for human or animal consumption.
Are these compounds for human use?
No. None of these compounds are for human use. Semaglutide, tirzepatide, retatrutide, AOD 9604, and tesamorelin are supplied strictly for laboratory and in-vitro research use only. They are not for human or animal consumption and are not drug products. While some of these peptides have approved or investigational pharmaceutical forms produced separately under regulated manufacturing, the research-grade material offered here must never be consumed, injected, or used in or on the body. It is intended solely as a research reagent for qualified laboratory professionals.
Create a free research account to view current pricing, real-time stock, and bundles, then submit your order for approval.
More research peptide questions
How to Order and Buy Research Peptides: Ordering FAQ · Shipping and Delivery Questions · Purity, Testing, and Certificates of Analysis (COA) · Peptide Reconstitution and Research Dosing Math: Reference FAQ · Research Peptide Storage, Handling, and Shelf Life · Research Peptide Legality, Regulations, and Research-Use Compliance
All questions & answers · What are peptides? · Research guides · Order portal